{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:09:57Z","timestamp":1787018997476,"version":"build-2736575974"},"reference-count":107,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Annals of Neurosciences"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Radiation-induced cognitive decline (RICD) is a common and debilitating late effect of cranial radiotherapy, particularly in long-term survivors of brain tumours and paediatric cancers. Despite advances in conformal radiation delivery and supportive care, progressive impairments in memory, attention and executive function continue to limit quality of life. Increasing evidence indicates that RICD is driven not by acute neuronal loss but by persistent neuroinflammation, oxidative stress, vascular dysfunction and metabolic failure within cognitive circuits. These converging processes highlight the need for disease-modifying targets that can regulate multiple pathological domains simultaneously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that integrate inflammatory control, redox balance, lipid metabolism and mitochondrial function across neurons, glia and the neurovascular unit. Preclinical studies demonstrate that PPAR\u03b3 and PPAR\u03b1 agonists, including pioglitazone and fenofibrate, prevent or attenuate cognitive decline after fractionated whole-brain irradiation even when structural injury persists. PPAR\u03b2\/\u03b4 agonists suppress radiation-induced neuroinflammation, while emerging evidence suggests that ligands capable of stabilising white matter and glial phenotypes may further enhance cognitive resilience. In parallel, phytochemical PPAR modulators, dual-isoform ligands, and advanced delivery strategies expand the therapeutic landscape beyond first-generation metabolic drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Message<\/jats:title>\n                    <jats:p>PPARs represent an integrative, circuit-level target for modifying the delayed trajectory of radiation-induced brain injury. Strategic deployment of PPAR-directed therapies during and after cranial radiotherapy offers a biologically grounded and clinically actionable approach to preserving long-term cognitive function in brain tumour survivors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09727531261452006","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:15:17Z","timestamp":1784117717000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological Targeting of Peroxisome \u2028Proliferator-activated Receptors for Prevention \u2028of Radiation-induced Cognitive Decline"],"prefix":"10.1177","author":[{"given":"Shubham","family":"Ghanekar","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemema Agnes Tripena","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"},{"name":"Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokula Krishnan","family":"Thiruselvan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucha","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Soni","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"},{"name":"Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-6233","authenticated-orcid":false,"given":"Ishan","family":"Patro","sequence":"additional","affiliation":[{"name":"School of Studies in Zoology, Jiwaji University, Gwalior, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3915-8927","authenticated-orcid":false,"given":"Jayant S.","family":"Goda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, Maharashtra, India"},{"name":"Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"e_1_3_7_2_2","article-title":"The global, regional, and national brain and CNS cancers burden and trends from 1990 to 2021","volume":"15","author":"Zhou J","year":"2025","unstructured":"Zhou J, , Gu L, , Du F, . The global, regional, and national brain and CNS cancers burden and trends from 1990 to 2021. Sci Rep 2025; 15: 19228.","journal-title":"Sci Rep"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18222"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115774"},{"key":"e_1_3_7_5_2","article-title":"Investigation of high-dose radiotherapy\u2019s effect on brain structure aggravated cognitive impairment and deteriorated patient psychological status in brain tumor treatment","volume":"14","author":"Ma J","year":"2024","unstructured":"Ma J, , Cao H, , Hou D, . Investigation of high-dose radiotherapy\u2019s effect on brain structure aggravated cognitive impairment and deteriorated patient psychological status in brain tumor treatment. Sci Rep 2024; 14: 10149.","journal-title":"Sci Rep"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16444"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2022.02.003"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-12887-6_24"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.3174\/ng.1700066"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad186"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217700"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.02.033"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02767"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa193"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.150026"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113764"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109954"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5134"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2020.1820598"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02596-7"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2021.11.023"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.11.067"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02375-9"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.04.061"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-11488-6_3"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70081"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60101682"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.11.059"},{"key":"e_1_3_7_29_2","first-page":"474","article-title":"Effect of rosiglitazone on amyloid precursor protein processing and A\u03b2 clearance in streptozotocin-induced rat model of Alzheimer\u2019s disease","volume":"20","author":"Wang L","year":"2017","unstructured":"Wang L, , Liu W, , Fan Y, . Effect of rosiglitazone on amyloid precursor protein processing and A\u03b2 clearance in streptozotocin-induced rat model of Alzheimer\u2019s disease. Iran J Basic Med Sci 2017; 20: 474\u2013480.","journal-title":"Iran J Basic Med Sci"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6386729"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081116"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02478-y"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/658520"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.09.002"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1667\/RR13202.1"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-024-10108-y"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.02.032"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.03.002"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.11.009"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.09.036"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2018.11.005"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2791-5"},{"key":"e_1_3_7_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2084-2"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11233"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114549"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10175"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13265"},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa062"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.06.059"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103994"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103452"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.01.118"},{"key":"e_1_3_7_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-06032-y"},{"key":"e_1_3_7_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf063"},{"key":"e_1_3_7_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-012-0781-6"},{"key":"e_1_3_7_56_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.398552"},{"key":"e_1_3_7_57_2","first-page":"15","article-title":"Association of pioglitazone with major adverse cardiovascular events, all-cause mortality, and heart failure hospitalizations: a systematic review","author":"Sheikh IM","unstructured":"Sheikh IM, , Hassan OA, , Adam SM, . Association of pioglitazone with major adverse cardiovascular events, all-cause mortality, and heart failure hospitalizations: a systematic review. Cureus 15. Epub ahead of print 12 October 2023. DOI: 10.7759\/cureus.46911","journal-title":"Cureus"},{"key":"e_1_3_7_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020352"},{"key":"e_1_3_7_59_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200220666190405171303"},{"key":"e_1_3_7_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93401-7"},{"key":"e_1_3_7_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9628-x"},{"key":"e_1_3_7_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1356-3"},{"key":"e_1_3_7_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.05.033"},{"key":"e_1_3_7_64_2","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2014.942015"},{"key":"e_1_3_7_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.10.054"},{"key":"e_1_3_7_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.08.004"},{"key":"e_1_3_7_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.102"},{"key":"e_1_3_7_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2024.100151"},{"key":"e_1_3_7_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.05.040"},{"key":"e_1_3_7_70_2","doi-asserted-by":"publisher","DOI":"10.1101\/lm.987808"},{"key":"e_1_3_7_71_2","article-title":"Novel PPAR-\u03b3 agonists as potential neuroprotective agents against Alzheimer\u2019s disease: rational design, synthesis, in silico evaluation, PPAR-\u03b3 binding assay and transactivation and expression studies","author":"D P","unstructured":"D P, , Hani U, , Haider N, . Novel PPAR-\u03b3 agonists as potential neuroprotective agents against Alzheimer\u2019s disease: rational design, synthesis, in silico evaluation, PPAR-\u03b3 binding assay and transactivation and expression studies. RSC Adv Epub ahead of print 21 October 2024. DOI: 10.1039\/D4RA06330A","journal-title":"RSC Adv"},{"key":"e_1_3_7_72_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061639"},{"key":"e_1_3_7_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.01.057"},{"key":"e_1_3_7_74_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043264"},{"key":"e_1_3_7_75_2","doi-asserted-by":"publisher","DOI":"10.1042\/AN20130030"},{"key":"e_1_3_7_76_2","first-page":"11","article-title":"The protective effects of peroxisome proliferator-activated receptor gamma in cerebral ischemia-reperfusion injury","author":"Ding Y","unstructured":"Ding Y, , Kang J, , Liu S, . The protective effects of peroxisome proliferator-activated receptor gamma in cerebral ischemia-reperfusion injury. Front Neurol 11. Epub ahead of print 17 November 2020. DOI: 10.3389\/fneur.2020.588516","journal-title":"Front Neurol"},{"key":"e_1_3_7_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2021.09.005"},{"key":"e_1_3_7_78_2","first-page":"7","article-title":"Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer\u2019s disease","author":"Liu Z-J","unstructured":"Liu Z-J, , Li Z-H, , Liu L, . Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer\u2019s disease. Front Pharmacol 7. Epub ahead of print 19 August 2016. DOI: 10.3389\/fphar.2016.00261","journal-title":"Front Pharmacol"},{"key":"e_1_3_7_79_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028668"},{"key":"e_1_3_7_80_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-022-03652-8"},{"key":"e_1_3_7_81_2","article-title":"Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPAR\u03b3","volume":"177","author":"da Silva Rodrigues F","year":"2024","unstructured":"da Silva Rodrigues F, , Newton WR, , Tassinari ID, . Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPAR\u03b3. Neurochem Int 2024; 177: 105769.","journal-title":"Neurochem Int"},{"key":"e_1_3_7_82_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032057"},{"key":"e_1_3_7_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156237"},{"key":"e_1_3_7_84_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001142"},{"key":"e_1_3_7_85_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082250"},{"key":"e_1_3_7_86_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050657"},{"key":"e_1_3_7_87_2","first-page":"11","article-title":"Pioglitazone reduces \u03b2 amyloid levels via inhibition of PPAR\u03b3 phosphorylation in a neuronal model of Alzheimer\u2019s disease","author":"Quan Q","unstructured":"Quan Q, , Qian Y, , Li X, . Pioglitazone reduces \u03b2 amyloid levels via inhibition of PPAR\u03b3 phosphorylation in a neuronal model of Alzheimer\u2019s disease. Front Aging Neurosci 11. Epub ahead of print 17 July 2019. DOI: 10.3389\/fnagi.2019.00178","journal-title":"Front Aging Neurosci"},{"key":"e_1_3_7_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh452"},{"key":"e_1_3_7_89_2","first-page":"065","article-title":"Preliminary screening of Pioglitazone and Diosgenin novel combination for Alzheimer\u2019s disease","volume":"13","author":"Mohammed S","year":"2023","unstructured":"Mohammed S, , Nandhyala A, , Gaddam NR, . Preliminary screening of Pioglitazone and Diosgenin novel combination for Alzheimer\u2019s disease. J App Pharm Sci 2023; 13: 065\u2013075.","journal-title":"J App Pharm Sci"},{"key":"e_1_3_7_90_2","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500233"},{"key":"e_1_3_7_91_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00516"},{"key":"e_1_3_7_92_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567202619666211217140954"},{"key":"e_1_3_7_93_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00737-2"},{"key":"e_1_3_7_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.11.004"},{"key":"e_1_3_7_95_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S171490"},{"key":"e_1_3_7_96_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030746"},{"key":"e_1_3_7_97_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00510"},{"key":"e_1_3_7_98_2","doi-asserted-by":"publisher","DOI":"10.1039\/D0NR06249A"},{"key":"e_1_3_7_99_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03168-4"},{"key":"e_1_3_7_100_2","article-title":"Predicting peroxisome proliferator-activated receptor gamma potency of small molecules: a synergistic consensus model and deep learning binding affinity approach powered by Enalos Cloud Platform","author":"Antoniou M","unstructured":"Antoniou M, , Papavasileiou KD, , Tsoumanis A, . Predicting peroxisome proliferator-activated receptor gamma potency of small molecules: a synergistic consensus model and deep learning binding affinity approach powered by Enalos Cloud Platform. Mol Divers. Epub ahead of print 14 June 2025. DOI: 10.1007\/s11030-025-11230-6","journal-title":"Mol Divers"},{"key":"e_1_3_7_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2024.108742"},{"key":"e_1_3_7_102_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29204881"},{"key":"e_1_3_7_103_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38508-8"},{"key":"e_1_3_7_104_2","first-page":"42","article-title":"APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge","author":"Lee S","unstructured":"Lee S, , Devanney NA, , Golden LR, . APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep 42. Epub ahead of print 28 March 2023. DOI: 10.1016\/j.celrep.2023.\u2028112196","journal-title":"Cell Rep"},{"key":"e_1_3_7_105_2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506313"},{"key":"e_1_3_7_106_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M808482200"},{"key":"e_1_3_7_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06446-3"},{"key":"e_1_3_7_108_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13064-025-00216-7"}],"container-title":["Annals of Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09727531261452006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09727531261452006","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09727531261452006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:46:23Z","timestamp":1784407583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09727531261452006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":107,"alternative-id":["10.1177\/09727531261452006"],"URL":"https:\/\/doi.org\/10.1177\/09727531261452006","relation":{},"ISSN":["0972-7531","0976-3260"],"issn-type":[{"value":"0972-7531","type":"print"},{"value":"0976-3260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"09727531261452006"}}